Israel - inglês - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - pneumococcal vaccine polyvalent - solution for injection - pneumococcal vaccine polyvalent 25 mcg / 0.5 ml - pneumococcus, purified polysaccharides antigen - pneumococcus, purified polysaccharides antigen - for vaccination against pneumococcal disease caused by those pneumococcal types included in the vaccine.

Israel - inglês - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - live attenuated oka/merck strain of varicella-zoster virus - powder and solvent for suspension for injection - live attenuated oka/merck strain of varicella-zoster virus 19400 pfu / 0.65 ml - zoster, live attenuated - zoster, live attenuated - zostavax is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older.

Cingapura - inglês - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - hepatitis a virus (inactivated) - injection - 50u/ml - hepatitis a virus (inactivated) 50u/ml

Cingapura - inglês - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - measles virus; mumps virus; rubella virus; varicella virus - injection, powder, lyophilized, for solution - 3.00 log tcid 50/ dose - measles virus 3.00 log tcid 50/ dose; mumps virus 4.30 log tcid 50/ dose; rubella virus 3.00 log tcid 50/ dose; varicella virus 3.99 log pfu/ dose

Cingapura - inglês - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - water for injection - injection - 0.85 ml - water for injection 0.85 ml

Cingapura - inglês - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - live attenuated oka/merck strain of varicella-zoster virus - injection, powder, lyophilized, for suspension - 19,400 pfu/dose - live attenuated oka/merck strain of varicella-zoster virus 19,400 pfu/dose

Cingapura - inglês - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - human-bovine rotavirus g1; human-bovine rotavirus g2; human-bovine rotavirus g3; human-bovine rotavirus g4; human-bovine rotavirus p1 - solution - 2.2 x exponential 6 infectious units - human-bovine rotavirus g1 2.2 x exponential 6 infectious units; human-bovine rotavirus g2 2.8 x exponential 6 infectious units; human-bovine rotavirus g3 2.2 x exponential 6 infectious units; human-bovine rotavirus g4 2.0 x exponential 6 infectious units; human-bovine rotavirus p1 2.3 x exponential 6 infectious units

Cingapura - inglês - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - human papillomavirus type 11 l1 protein; human papillomavirus type 16 l1 protein; human papillomavirus type 18 l1 protein; human papillomavirus type 6 l1 protein - solution, sterile - 40 mcg - human papillomavirus type 11 l1 protein 40 mcg; human papillomavirus type 16 l1 protein 40 mcg; human papillomavirus type 18 l1 protein 20 mcg; human papillomavirus type 6 l1 protein 20 mcg

Cingapura - inglês - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - human papillomavirus type 11 l1 protein; human papillomavirus type 16 l1 protein; human papillomavirus type 18 l1 protein; human papillomavirus type 6 l1 protein - solution, sterile - 40 mcg - human papillomavirus type 11 l1 protein 40 mcg; human papillomavirus type 16 l1 protein 40 mcg; human papillomavirus type 18 l1 protein 20 mcg; human papillomavirus type 6 l1 protein 20 mcg

Cingapura - inglês - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - protein (hbsag) - injection - 10 mcg/ml - protein (hbsag) 10 mcg/ml